Table 3 Univariate and multivariate Cox proportional hazards model analysis for overall survival

Age

0.023

0.013

  ≤ 57

Reference

Reference

 >57

1.053–2.020

1.091–2.129

Gender

0.139

 Male

Reference

 Female

0.556–1.086

Smoking history

0.120

 Y

Reference

 N

0.563–1.068

Stage

<0.001

0.051

 I-II

Reference

Reference

 IIIA

2.279–4.148

0.997–3.060

Pathological tumor

Classification (pT)

0.009

0.285

 pT1–2

Reference

Reference

 pT3–4

1.138–2.430

0.806–2.078

Pathological lymph node

stage (pN)

<0.001

<0.001

 pN0

Reference

Reference

 pN1–2

2.772–5.323

2.694–7.767

Histological type

0.136

 Squamous cell carcinoma

Reference

 Adenocarcinoma

0.611–1.173

 Large cell carcinoma

0.815–2.305

Surgery type

<0.001

0.613

 Lobectomy

Reference

Reference

 Pneumonectomy

1.719–3.293

0.760–2.056

 Other

1.316–3.781

0.543–1.938

Adjuvant chemotherapy

<0.001

0.002

 Y

Reference

Reference

 N

1.596–3.006

1.439–4.723

GLU (mmol/L)

0.115

  ≤ 5.75

Reference

 >5.75

0.542–1.068

TC (mmol/L)

0.490

  ≤ 4.59

Reference

 >4.59

0.655–1.225

TG (mmol/L)

<0.001

<0.001

  ≤ 1.21

Reference

Reference

 >1.21

1.640–2.997

1.385–2.583

HDL-C (mmol/L)

<0.001

<0.001

  ≤ 1.26

Reference

Reference

 >1.26

0.260–0.527

0.301–0.613

LDL-C (mmol/L)

0.046

0.742

  ≤ 2.26

Reference

Reference

 >2.26

1.006–1.945

0.752–1.492

ApoA1(g/L)

0.181

  ≤ 1.21

Reference

 >1.21

0.597–1.102

ApoB(g/L)

0.222

  ≤ 1.15

Reference

 >1.15

0.434–1.214

Lpa (mg/L)

0.374

  ≤ 53

Reference

 >53

0.546–1.256